Equivalent price position
Unlock the full competitive price benchmark
See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Lenalidomide
- Therapeutic area
- Oncology & immunology
- Drug class
- Antineoplastic medicines
- ATC
- L01
- Strength
- 25 mg
- Dosage form
- Capsule
- Pack
- 10's
- Registration no.
- 122516
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-11-13 03:02
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →What Rivelime (Lenalidomide) is used for
Lenalidomide is a cancer medicine taken as capsules. It belongs to a group called immunomodulatory medicines, which act on the immune system. It helps stop cancer cells from growing, stops new blood vessels from feeding the cancer, and helps the immune system attack cancer cells. It is started and supervised only by specialist doctors who treat blood cancers. Because it can cause severe birth defects, it is only supplied under a strict pregnancy prevention programme.
- Multiple myeloma (a cancer of plasma cells in the bone marrow), in adults: on its own as maintenance treatment after a stem cell (bone marrow) transplant, or together with other medicines such as dexamethasone
- Anaemia caused by certain myelodysplastic syndromes (MDS), a group of bone marrow disorders, in adults who need blood transfusions and have a particular gene change (5q deletion)
- Mantle cell lymphoma, in adults whose lymphoma has come back or not responded after earlier treatment
- Follicular lymphoma, together with rituximab, in adults who have had treatment before
- In the US it is also approved, with rituximab, for marginal zone lymphoma that has been treated before
- WHO includes it on its Model List of Essential Medicines for plasma cell myeloma
Get medical help straight away if
- Call an ambulance or go to the emergency department for signs of a severe allergic reaction: swelling of the face, lips, tongue or throat, or trouble breathing.
- Call an ambulance or go to the emergency department if you think you have sepsis (a life-threatening reaction to infection). Infections can become dangerous within hours.
- Contact your specialist team or hospital advice line straight away for any sign of infection, such as a high temperature, feeling cold and shivery, sweats, sore throat, cough, breathlessness, diarrhoea or pain when passing urine.
- Get urgent help for a painful, red, swollen leg, chest pain or sudden shortness of breath. These can be signs of a blood clot in the leg or lungs.
Side effects, warnings and interactions for Lenalidomide
Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.
About Rivelime 25 mg capsule
Rivelime 25 mg capsule contains Lenalidomide 25 mg. It is registered with DRAP by Martin Dow Limited (registration no. 122516). Its official price is PKR 16,747.57 for a pack of 10's, about PKR 1,674.76 per capsule. This price has applied since 23 July 2026. It is sold in 3 pack sizes: 7's, 10's and 3x7's. Rivelime is also available as 10 mg capsule. 5 other brands of Lenalidomide 25 mg (capsule) are registered in Pakistan. Compare all brands and prices →
Rivelime 25 mg pack sizes and prices
Other strengths of Rivelime
All 5 other brands of Lenalidomide 25 mg capsule in Pakistan
These 5 brands are alternatives (substitutes) to Rivelime: each contains Lenalidomide 25 mg capsule. Ask your doctor or pharmacist before you switch brands.
Sorted by price per capsule, lowest first. The lowest is Lenava (The Searle Company Limited) at PKR 1,116 per capsule; the highest is Linamide at PKR 1,675. All prices are official DRAP prices.
| Brand | Company | Pack | Official price | Per unit |
|---|---|---|---|---|
| Lenava | The Searle Company Limited | 1x7's | PKR 7,812.00 | PKR 1,116 / capsule |
| Lemiryl | Oncogen Pharma (Pvt) Limited | 21's | PKR 27,142.76 | PKR 1,293 / capsule |
| LENMID | AJM Pharma (Pvt.) Limited | 7's | PKR 11,171.43 | PKR 1,596 / capsule |
| Relidomide | Helix Pharma (Pvt)., Ltd | 7's | PKR 11,723.30 | PKR 1,675 / capsule |
| Linamide | Himmel Pharmaceuticals Private Limited | 18's | PKR 30,146.91 | PKR 1,675 / capsule |
Where to buy
MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Rivelime, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.
- Registration holder
- Martin Dow Limited, Karachi
- DRAP registration
- 122516
- Phone
- +92 21 111 111 634
- info@martindow.com
- Website
- https://www.martindowltd.com/
- Contact page
- Company contact page
Contact details as published by the company, last checked on 16 August 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.
Official price over time
No change in the official DRAP price is recorded for this pack (10's). Current price PKR 16,747.57, effective 23 Jul 2026.
Cite this price history
MedInfoBase. Rivelime 25 mg, 10's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rivelime-25-mg-122516-10s-martin-dow-limited/ (accessed 13 November 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 16,747.57 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Cite this record
Medicine record · DRAP registration 122516Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.